AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AC012215.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC021218.2 | Uncharacterized protein | | | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | | | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | | | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ASAH2B | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B | | | | | | Tissue enhanced |
ASIC5 | Acid-sensing (proton-gated) ion channel family member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
BAIAP2L2 | BAI1-associated protein 2-like 2 | | | | | | Tissue enhanced |
BCMO1 | Beta-carotene 15,15'-monooxygenase 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C19orf77 | Chromosome 19 open reading frame 77 | Predicted membrane proteins
| | | | | Tissue enhanced |
C6orf222 | Chromosome 6 open reading frame 222 | | | | | | Tissue enhanced |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-2545M3.6 | | | | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | | | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | | | | | | Tissue enhanced |
FADS6 | Fatty acid desaturase 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM132A | Family with sequence similarity 132, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM211A | Family with sequence similarity 211, member A | | | | | | Tissue enhanced |
FAM3B | Family with sequence similarity 3, member B | Predicted membrane proteins
| | | | | Tissue enhanced |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FUT2 | Fucosyltransferase 2 (secretor status included) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GAL3ST1 | Galactose-3-O-sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GCNT1 | Glucosaminyl (N-acetyl) transferase 1, core 2 | Enzymes
| | | | | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |